We have also developed a technology for the production of recombinant proteins in transgenic alfalfa. Transgenic alfalfa is best suited for the production of recombinant proteins required in high volumes and for which a relatively long lead time – up to six months – is not an issue. While this technology is not suited for the production of vaccines, we believe it may have applications in other field of interest such as the production of enzymes for biofuels.